BioWorld

Nov. 16, 2010

Primate Spinal Cord Recovery Greater than Rat Studies Show

'Stratified Medicine' Shatters Bio-Pharma Partnering Model

Stock Movers

Other News To Note

Clinic Roundup

Specialty Pharma Firm AcelRx Joins IPO Queue: $86M Filing

AcelRx Pharmaceuticals Inc. joined the initial public offering (IPO) queue, filing to raise up to $86.25 million in its debut. (BioWorld Today) Read More

Cerulean Pushing Nano-based Pipeline via $24M Series C

AHA Roundup

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026